BRNS
Price
$1.18
Change
+$0.26 (+28.26%)
Updated
Dec 18, 04:05 PM (EDT)
93 days until earnings call
IMVT
Price
$26.72
Change
-$1.19 (-4.26%)
Updated
Dec 18, 04:19 PM (EDT)
56 days until earnings call
Ad is loading...

BRNS vs IMVT

Header iconBRNS vs IMVT Comparison
Open Charts BRNS vs IMVTBanner chart's image
Barinthus Biotherapeutics
Price$1.18
Change+$0.26 (+28.26%)
Volume$900
CapitalizationN/A
Immunovant
Price$26.72
Change-$1.19 (-4.26%)
Volume$801
CapitalizationN/A
BRNS vs IMVT Comparison Chart
Loading...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRNS vs. IMVT commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRNS is a Hold and IMVT is a Buy.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (BRNS: $0.92 vs. IMVT: $27.91)
Brand notoriety: BRNS and IMVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRNS: 134% vs. IMVT: 87%
Market capitalization -- BRNS: $37.13M vs. IMVT: $4.06B
BRNS [@Biotechnology] is valued at $37.13M. IMVT’s [@Biotechnology] market capitalization is $4.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRNS’s FA Score shows that 1 FA rating(s) are green whileIMVT’s FA Score has 0 green FA rating(s).

  • BRNS’s FA Score: 1 green, 4 red.
  • IMVT’s FA Score: 0 green, 5 red.
According to our system of comparison, BRNS is a better buy in the long-term than IMVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRNS’s TA Score shows that 5 TA indicator(s) are bullish while IMVT’s TA Score has 5 bullish TA indicator(s).

  • BRNS’s TA Score: 5 bullish, 5 bearish.
  • IMVT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both BRNS and IMVT are a good buy in the short-term.

Price Growth

BRNS (@Biotechnology) experienced а -1.81% price change this week, while IMVT (@Biotechnology) price change was -3.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.43%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

BRNS is expected to report earnings on Mar 21, 2025.

IMVT is expected to report earnings on Feb 12, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMVT($4.06B) has a higher market cap than BRNS($37.1M). IMVT YTD gains are higher at: -33.753 vs. BRNS (-74.986). BRNS has higher annual earnings (EBITDA): -52.89M vs. IMVT (-352.16M). IMVT has more cash in the bank: 473M vs. BRNS (106M). IMVT has less debt than BRNS: IMVT (47K) vs BRNS (12.7M). BRNS has higher revenues than IMVT: BRNS (15M) vs IMVT (0).
BRNSIMVTBRNS / IMVT
Capitalization37.1M4.06B1%
EBITDA-52.89M-352.16M15%
Gain YTD-74.986-33.753222%
P/E RatioN/AN/A-
Revenue15M0-
Total Cash106M473M22%
Total Debt12.7M47K27,021%
TECHNICAL ANALYSIS
Technical Analysis
BRNSIMVT
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 6 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
FOREX / NAMEPrice $Chg $Chg %
EURJPY162.05N/A
N/A
Euro - Japan Yen
JPYEUR0.01N/A
N/A
Japan Yen - Euro
FSVLX20.10N/A
N/A
Fidelity Select Fintech Port
CADUSD0.70N/A
N/A
Canadian Dollar - United States Dollar
PFFA22.36-0.09
-0.40%
Virtus InfraCap US Preferred Stock ETF

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with SLNO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then SLNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
-5.26%
SLNO - BRNS
56%
Loosely correlated
-0.58%
NGNE - BRNS
51%
Loosely correlated
-5.61%
BNOX - BRNS
50%
Loosely correlated
-4.24%
IMVT - BRNS
48%
Loosely correlated
+1.01%
TARA - BRNS
35%
Loosely correlated
+1.63%
More

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
+1.01%
ROIV - IMVT
56%
Loosely correlated
+0.41%
BRNS - IMVT
48%
Loosely correlated
-5.26%
ARGX - IMVT
45%
Loosely correlated
+0.90%
RVMD - IMVT
38%
Loosely correlated
+1.01%
SNDX - IMVT
38%
Loosely correlated
-1.16%
More